Ipamorelin + CJC-1295
Growth Hormone Secretagogue Combo • 5mg + 5mg
Research Overview
This combination pairs Ipamorelin (a selective ghrelin receptor agonist) with CJC-1295 (a growth hormone releasing hormone analog). It has been studied in research models for its synergistic effects on growth hormone release from the pituitary gland.
Mechanism of Action (Laboratory Research)
Research indicates the combination may stimulate endogenous growth hormone secretion through complementary pathways, allowing investigation of pulsatile GH release patterns and downstream IGF-1 effects in laboratory settings.
Key Published Research Areas
- Synergistic stimulation of growth hormone release
- Pulsatile GH secretion patterns in research models
- Downstream effects on IGF-1 pathways
- Comparative studies of single vs combination secretagogues
Note: All referenced research is from preclinical studies. Sold strictly for laboratory research use only.
• Ipamorelin: C38H49N9O5
• CJC-1295: Modified GHRH analog
• Purity: ≥99.9% (HPLC + MS verified)
• Appearance: White lyophilized powder
• Storage (lyophilized): -20°C or below
Reconstitution & Handling
Reconstitute with 1–2 ml of bacteriostatic water. Gently swirl until dissolved. Do not shake. Store reconstituted solution at 2–8°C and use within 14–28 days.